Qualité GMP Standard Cilostazol CAS  73963-72-1  Cilostazol Powder 99% Purity  Under CDE usine
Qualité GMP Standard Cilostazol CAS  73963-72-1  Cilostazol Powder 99% Purity  Under CDE usine
Qualité GMP Standard Cilostazol CAS  73963-72-1  Cilostazol Powder 99% Purity  Under CDE usine
Qualité GMP Standard Cilostazol CAS  73963-72-1  Cilostazol Powder 99% Purity  Under CDE usine

Résumé du produit

Cilostazol (CAS 73963-72-1) Product Details High-quality Cilostazol for pharmaceutical and industrial use, compliant with international standards, suitable for global export. Professional documentation and stable supply chain support your business needs. Product Overview Cilostazol (CAS 73963-72-1) ...

GMP Standard Cilostazol CAS 73963-72-1 Cilostazol Powder 99% Purity Under CDE

Propriétés de base

Lieu d'origine: Chine
Nom de la marque: Bovita
Attestation: ISO/GMP
Numéro de modèle: BVTC04

Propriétés commerciales

Quantité minimum de commande: 5g
Prix: 50usd/g
Emballage standard: 10g/sac de papier d'aluminium
Conditions de paiement: LC, D/A, D/P, T/T, Western Union
Capacité d'approvisionnement: 10kg/mois
Détails de produit
Mettre en évidence:

GMP Standard Cilostazol Powder

,

Cilostazol API 99% Purity

,

CDE Approved Cilostazol CAS 73963-72-1

Shelflife: 24 à 36 mois
Color: Poudre blanche
Storageconditions: Conserver dans un endroit frais et sec, à l'abri de la lumière du soleil
CAS: Les autres produits
Delivery: 3-5 jours
Payment Terms: T/T, DP/DA/LC/union occidentale
Description de produit
Spécifications détaillées et caractéristiques
  • Cilostazol (CAS 73963-72-1) Product Details
    High-quality Cilostazol for pharmaceutical and industrial use, compliant with international standards, suitable for global export. Professional documentation and stable supply chain support your business needs.

    Product Overview

    Cilostazol (CAS 73963-72-1) is a potent antiplatelet and vasodilator agent belonging to the phosphodiesterase III (PDE III) inhibitor class. It exerts its pharmacological effects by inhibiting the degradation of cyclic adenosine monophosphate (cAMP), thereby increasing cAMP levels in platelets and vascular smooth muscle cells. This mechanism helps inhibit platelet aggregation and dilate blood vessels, effectively improving blood circulation. Our Cilostazol is manufactured under strict quality control systems to meet high international pharmaceutical standards, suitable for pharmaceutical formulation development and industrial applications.
    Item
    Specification
    CAS Number
    73963-72-1
    Molecular Formula
    C₂₀H₂₇N₅O₂
    Molecular Weight
    369.47
    Appearance
    Off-white to grayish white crystalline powder
    Odor
    Odorless
    Solubility
    Freely soluble in acetic acid and chloroform; slightly soluble in methanol; almost insoluble in water and
    Assay (Dried Basis)
    98.0% – 102.0%
    Loss on Drying
    ≤ 0.5%
    Heavy Metals
    ≤ 10 ppm
    Storage Condition
    20°C to 25°C, in tight, light-resistant containers, protected from moisture

    Quality Specifications

    Our Cilostazol strictly complies with USP/EP/CP standards, with strict impurity control to ensure safety and stability for pharmaceutical use. Related substances meet international pharmacopoeia requirements, and the product undergoes rigorous testing in accordance with USP standards for higher quality assurance. Particle size can be customized according to customer needs.

    Main Applications

    • Improvement of symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerotic occlusion.
    • Treatment of chronic arterial occlusion caused by atherosclerosis, Takayasu arteritis, thromboangiitis obliterans and diabetes mellitus.
    • Supplementary treatment after surgical treatment of the above diseases to assist in relieving symptoms, improving circulation and inhibiting thrombosis in transplanted blood vessels.
    • Used in pharmaceutical formulations including tablets and capsules, commonly in 50mg and 100mg specifications for oral administration.

    Features & Advantages

    • High purity with stable quality, compliant with USP, EP, CP standards, and strictly controlled in accordance with international pharmacopoeia requirements.
    • Strict impurity control and complete quality testing to ensure safe and reliable pharmaceutical use.
    • Stable production capacity and reliable supply chain, ensuring timely delivery and stable supply for global customers.
    • Complete documentation: COA, MSDS, DMF (available on request), facilitating customs clearance and product certification.
    • Custom packaging and professional technical support available to meet diverse customer needs.

    Packaging & Storage

    • Packaging: 1kg/bag, 5kg/bag, 25kg/drum or customized according to customer requirements; blister pack and cardboard box packaging are also available for finished formulations.
    • Storage Conditions: Preserve in tight, light-resistant containers, store at 20°C to 25°C (USP controlled room temperature), protected from moisture and heat.
    • Transportation: Non-hazardous for general transport; transported at room temperature (15-30°C), comply with local chemical and pharmaceutical shipping regulations, and properly labeled.

GMP Standard Cilostazol CAS  73963-72-1  Cilostazol Powder 99% Purity  Under CDE 0



Notation globale
5.0
★★★★★
★★★★★
Basé sur 50 critiques récemment
cinq étoiles
100%
4 étoiles
0
3 étoiles
0
2 étoiles
0
1 étoile
0
Toutes les critiques
  • J
    Jack
    France Mar 7.2026
    ★★★★★
    ★★★★★
    I buy many times, i like it
  • J
    Justin
    Germany Mar 7.2026
    ★★★★★
    ★★★★★
    very good high purity, good use
  • M
    Marc
    Argentina Mar 3.2026
    ★★★★★
    ★★★★★
    Very good price, helped my business
Demandez une citation

Veuillez utiliser notre formulaire de contact en ligne ci-dessous si vous avez des questions, notre équipe vous contactera dès que possible.

Vous pouvez télécharger jusqu'à 5 fichiers et chaque fichier de 10M de taille max.